163 related articles for article (PubMed ID: 30568255)
1. Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day.
Ludgate M
Eye (Lond); 2019 Feb; 33(2):169-173. PubMed ID: 30568255
[TBL] [Abstract][Full Text] [Related]
2. The insulin-like growth factor-I receptor and its role in thyroid-associated ophthalmopathy.
Smith TJ
Eye (Lond); 2019 Feb; 33(2):200-205. PubMed ID: 30385883
[TBL] [Abstract][Full Text] [Related]
3. Immunological Aspects of Graves' Ophthalmopathy.
Łacheta D; Miśkiewicz P; Głuszko A; Nowicka G; Struga M; Kantor I; Poślednik KB; Mirza S; Szczepański MJ
Biomed Res Int; 2019; 2019():7453260. PubMed ID: 31781640
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?
Wiersinga WM
J Clin Endocrinol Metab; 2011 Aug; 96(8):2386-94. PubMed ID: 21677036
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
Khoo TK; Bahn RS
Thyroid; 2007 Oct; 17(10):1013-8. PubMed ID: 17935483
[TBL] [Abstract][Full Text] [Related]
6. The pathophysiology of thyroid eye disease: implications for immunotherapy.
Douglas RS; Gupta S
Curr Opin Ophthalmol; 2011 Sep; 22(5):385-90. PubMed ID: 21730841
[TBL] [Abstract][Full Text] [Related]
7. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
[TBL] [Abstract][Full Text] [Related]
8. [Current understanding of pathogenesis of Graves ophthalmopathy].
Ando T; Eguchi K
Nihon Rinsho; 2006 Dec; 64(12):2275-8. PubMed ID: 17154091
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
Wall JR; Lahooti H
Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
[TBL] [Abstract][Full Text] [Related]
10. Is There Evidence for IGF1R-Stimulating Abs in Graves' Orbitopathy Pathogenesis?
Krieger CC; Neumann S; Gershengorn MC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911689
[TBL] [Abstract][Full Text] [Related]
11. Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy.
Roos JCP; Paulpandian V; Murthy R
Eye (Lond); 2019 Feb; 33(2):212-217. PubMed ID: 30401900
[TBL] [Abstract][Full Text] [Related]
12. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
[TBL] [Abstract][Full Text] [Related]
13. Future Prospects for the Treatment of Graves' Hyperthyroidism and Eye Disease.
Neumann S; Place RF; Krieger CC; Gershengorn MC
Horm Metab Res; 2015 Sep; 47(10):789-96. PubMed ID: 26197854
[TBL] [Abstract][Full Text] [Related]
14. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.
Marinò M; Rotondo Dottore G; Ionni I; Lanzolla G; Sabini E; Ricci D; Sframeli A; Mazzi B; Menconi F; Latrofa F; Vitti P; Marcocci C; Chiovato L
J Endocrinol Invest; 2019 Apr; 42(4):471-480. PubMed ID: 30132285
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
Wall JR; Lahooti H
Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
[TBL] [Abstract][Full Text] [Related]
16. Insulin-Like Growth Factor Pathway and the Thyroid.
Smith TJ
Front Endocrinol (Lausanne); 2021; 12():653627. PubMed ID: 34149612
[TBL] [Abstract][Full Text] [Related]
17. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
McLachlan SM; Bahn R; Rapoport B
Autoimmunity; 1992; 14(2):143-8. PubMed ID: 1363894
[TBL] [Abstract][Full Text] [Related]
18. [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].
Eckstein A; Mann K; Kahaly GJ; Grussendorf M; Reiners C; Feldkamp J; Quadbeck B; Bockisch A; Schott M
Med Klin (Munich); 2009 May; 104(5):343-8. PubMed ID: 19444414
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis of thyroid eye disease: emerging paradigms.
Naik VM; Naik MN; Goldberg RA; Smith TJ; Douglas RS
Surv Ophthalmol; 2010; 55(3):215-26. PubMed ID: 20385333
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of thyroid eye disease.
Shan SJ; Douglas RS
J Neuroophthalmol; 2014 Jun; 34(2):177-85. PubMed ID: 24821101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
